0      0

2021 APAC Pharmaceutical Manufacturing Conference and Global Regulatory Summit

VL21CEJUN1/SESCS3 - CASE STUDY 3: Critical Review of Quality and Manufacturing Data


Jun 17, 2021 5:00am ‐ Jun 17, 2021 5:40am


Description

CASE STUDY 3: Critical Review of Quality and Manufacturing Data | Emer-Pen is part of General-Pharma’s auto-injector portfolio. It is a single-use drug-device combination product, comprising device components with sterile injectable solution cartridge. Emer-Pen is used in life-threatening emergencies prior to gaining access to qualified medical care. Approximately 4 million packs (2 devices per pack) were prescribed in the local market during financial year 2015-16.

Moderator(s):

You must be logged in and own this session in order to post comments.